| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Vaxart, Inc. | Director | Stock Option (right to buy) | 15.1K | Jun 16, 2021 | Direct | ||
| Elicio Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 4.1K | Nov 21, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ELTX | Elicio Therapeutics, Inc. | Nov 21, 2024 | 1 | $0 | 4 | Nov 25, 2024 | Director |
| ELTX | Elicio Therapeutics, Inc. | Dec 28, 2023 | 1 | $0 | 4 | Dec 29, 2023 | Director |
| ELTX | Angion Biomedica Corp. | Jun 9, 2022 | 1 | $0 | 4 | Jun 13, 2022 | Director |
| VXRT | Vaxart, Inc. | Jun 16, 2021 | 1 | $0 | 4 | Jun 17, 2021 | Director |